Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study

Background: Pirfenidone, an antifibrotic medication approved for the treatment of idiopathic pulmonary fibrosis (IPF), often requires dose reduction owing to adverse events. In this study, we evaluated if pirfenidone's reduced dose has any impact on clinical outcomes in patients with IPF.Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Jieun Kang (Author), Man Pyo Chung (Author), Moo Suk Park (Author), In Jae Oh (Author), Heung Bum Lee (Author), Young Whan Kim (Author), Jong Sun Park (Author), Soo Taek Uh (Author), Yun Seong Kim (Author), Yangjin Jegal (Author), Jin Woo Song (Author)
Format: Book
Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available